medigraphic.com

2000, Number 6

<< Back Next >>

Arch Cardiol Mex 2000; 70 (6)

Cardiac rehabilitation in ischemic patients rejected for coronary by-pass surgery

Leyva GMA, Ramírez ROHA

Language: Spanish
References: 35
Page: 552-560
PDF size: 149.76 Kb.


ABSTRACT

Cardiac rehabilitation program was implemented on 65 patients rejected for bypass surgery and/or coronary angioplasty. The group was formed by 63 males (96.9%), 2 females (3.0). Their ages ranged from 54.5 ± 8.7 year (mean ± SD). Their risk's factors, were (RF): cigarette smoking, 25 patients (38.6%), hypercholesterolemia 47 (72.3%), hypertriglyceridemia 48 (73.8%), hypertension 33 (50.7%), diabetes mellitus 33 (46.1%), myocardial infarction 56 (86.1%). Coronary arteriography showed one vessel disease (25.5%), two vessels (38.3%) and three (36.1%). Ejection fraction (EF) › 50% in 39 (60%). The features evaluated were: number of obstructed vessels, (EF) and age. Results: One patient died, fifty two (80%) were asymptomatic ten showed stable angina (15.3%) and three (4.6%) unstable angina. Tobacco addiction decreased by 92%. Hypertension was controlled in 42.2%. Hypercholesterolemia was normalized in 82.9%. Hypertrigliceridemia improved in 53%. Oxygen uptake VO2 and Oxygen pulse PO2 improved in 42 patients (64.6%). Cardiac rehabilitation is a good alternative to improve quality of life in patients in whom a coronary revascularization is not feasible.


REFERENCES

  1. Anderson KM, Castelli WP, Levy D: Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176-80.

  2. Gofman JW, Young W, Tandy R: Ischemic heart disease, atherosclerosis and longevity. Circulation 1966; 34: 679-690.

  3. Selwyn AP, Ganz P: The effect of cholesterol lowering and antioxidant the therapy on endothelium dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493.

  4. Lipid Rescarch Clinic Program: The lipid research clinic coronary primary prevention trial result II. The relationship up reduction incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.

  5. Buchwald H, Varco RL, Matts JP, Jhon ML, Fitch LL, Campbell GS et al: Effect of partial ileal bypass surgery on mortality and morbity from coronary heart disease in pat ents with hipercholesterolemia. Report of the Program on the surgical Control of the Hyperlipidemia (POSCH). N Engl J Med 1990; 323: 946-955.

  6. Lipid Research Program: The Lipid Research Clinic Coronary Primary. Prevention Trial results I Reduction in the incidence of coronary heart disease. JAMA 1984; 251: 351-354.

  7. Lipid Reseach Program: The Lipid Research Clinics Coronary Primary Prevention Trial result II. The relations-chip of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.

  8. The Secandinavian Simvastatin Survival Study Group. Randomised trial of cholestesterol lowering in 4444 patients with coronary heart disease the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-1389.

  9. Ost RC, Stenson S: Regresion of peripheral ateroesclerosis during therapy with high doses of nicotinic acid. Scand J Clin Lab Invest 1967; 99: 241-245.

  10. Vos J, de Feyter PJ, Simoons ML, Tijssen JG, Deckers JW: Retardation and arrest of progression or regression of coronary artery disease: A review. Prog Cardiovas Dis 1993; 35: 435-454.

  11. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial: Lancet 1990; 336: 129-133.

  12. Ornish D, Scherwltz LW, Billings JH, Gould KL, Merritt TA, Sparler S et al: Intensive Lifestyle Changes for reversal of Coronary Heart Disease. JAMA 1998; 280: 2001-2007.

  13. Shuler G, Hambrecht R, Shilerf G, Niebauer J, Hauer K, Neumann J, et al: Regular Physical exercise and low fat diet: Effects on progresion of coronary artery disease. Circulation 1992; 86: 1-11.

  14. Levi D, Kannel WB: Cardiovascular risks: new insights from Framingham. Am Heart J 1988; 116: 266-272.

  15. Austin MA: Epidemiologic associations between hypertriglyceridemia and coronary heart disease. Semin Thromb Hemost 1988; 14: 187-142.

  16. Guillman MW, Kannel WB, Belager A, D’agostino R: Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 1993; 125: 1148-1154.

  17. Kannel WB, Cobb J: Left ventricular hypertrophy and mortality-results from the Framingham study. Cardiology 1992; 81: 291-298.

  18. Weber KT, Sun Y: Guarda E: Structural remodeling in hypertensive, heart disease and the role of hormona. Hypertension 1994; 23: 869-877.

  19. Hypertension detection and Follow-up Program Cooperative Group: Five years findings of hypertension detection and follow up program. JAMA 1979; 242: 2652-2671.

  20. Hansson L, Zanchetti A, Carruthers S, Dahlöf B, Elmfeld D, Julius S, et al: Efecto del tratamiento hipotensor intensivo aunado a dosis bajas de aspirina en pacientes hipertensos: Principales resultados del estudio aleatorizado sobre tratamiento óptimo de la hipertensión (HOT). Lancet 1998; 351: 1755-1963.

  21. Zanettini R, Bettega D, Agostoni O, Ballestra B, del Rosso G, Michele R, et al: Ejercise training in mild hypertension effect on blood presure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 1997; 88(5): 468-473.

  22. Hopkings P, Williams R: A survey of 246 sugested coronary risks factors. Atheroesclerosys 1981; 40: 1-52.

  23. Doll R, Peto R, Whealtley K, Gray R, Sutherland I: Mortality in relation to smoking: 40 years observations on male British doctors. Br Med J 1994; 309: 901-911.

  24. Kawachi I, Colditz GA, Stampfer MJ, Willett W, Manson J, Rosner B: Smoking cessation in relation to total mortality rates in women: A prospective cohort study. Ann Intern Med 1993; 119: 992-1000.

  25. Jonas MA, Oates JA, ckene JK: Hennekens CH: Statement on smokin and cardiovascular disease for healt care professionals: AHA Medical Scientific Statement. Circulation 1992; 86: 1664-1669.

  26. Galan KM, Deligonul U, Kem MJ, Chaitman BR, Vandormael MG: Increased frequency of restenosis in patients continuing to somoke cigarettes afther percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61: 260-263.

  27. Alberg A, Bergsrand R: Cessation of smoking after myocardial infarction; effects on mortality after 10 years. Br Heart J 1983; 49: 416-422.

  28. Salone JT: Stopping smoking and long-term mortalily after acute myocardial infarction. Br Heart J 1980; 43: 463-469.

  29. Suarez L, Barret CE: Interact between cigarett smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984; 120: 670-675.

  30. Dafoe W, Huston P: Current trends in cardiac rehabilitation. Can Med Assoc l997; 156: 527-532.

  31. Kavanagh T, Myers MG, Baigrie RS, Mertens DJ, Sawyer P, Shephard RJ: Quality of life and cardiorespiratory function in chronic heart failure. Heart 1996; 76: 42-49.

  32. Beniamin Y, Rubenstein JJ, Zaichkowky LD. Effects of hig intensity strongth training on quality of life parameters in cardiac rehabilitation patients. Am J Cardiol 1997; 80: 841-847.

  33. Digenio AG, Noakest TD, Cantor A, Groenveld H, Daly L, Mavunda D, et al. Predictors of exercise capacity and adaptability to training in patients with coronary artery disease. J Cardiopulm Rehabil 1997; 17: 110-120.

  34. Dubach P, Myers J, Dziekan G, Goebbels U, Reinhart W, Vogt P, et al: Effect of exercise on myocardial remodeling in patients with reduced left ventricular function after myocardial infarction: application of magnetic resonance imaging. Circulation 1997; 95: 2060-2067.

  35. Lavie CJ, Milani RV: Effects of cardiac rehabilitation, exercise training; and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 1997; 79: 397-401.




2020     |     www.medigraphic.com